Severe non-atopic asthma: omalizumab can reduce severe asthma exacerbations

Melscoet, L; Khayath, N; Migueres, N; Goltzene, MA; Meyer, N; de Blay, F

de Blay, F (通讯作者),Hop Univ Strasbourg, Hop Civil, Chest Dis Dept, BP 426,1 Pl hop, F-67091 Strasbourg, France.

JOURNAL OF ASTHMA, 2023; 60 (5): 881

Abstract

Introduction Humanized monoclonal anti-IgE antibody (omalizumab) has demonstrated efficacy in severe atopic asthma. However, few studies have assessed......

Full Text Link